| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $10,046,262 ) (Continued on the next page) |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM122517 | Structural Bioinformatics of Proteins and Protein Complexes and Applications to Cancer Biology | 001 | 7 | NIH | 3/12/2024 | $670,032 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA288297 | Addressing the Training Gap in Oncology on Sexual Health: Development of the Sexual Health Integrative Fellowship Training (SHIFT) Course for Hematology-Oncology Fellows | 000 | 1 | NIH | 4/2/2024 | $162,000 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA286669 | Divergent Functions of ERK2 Substrate Binding Domains in Pathogenesis of KRAS-Driven Pancreatic Cancer | 000 | 1 | NIH | 12/13/2023 | $94,000 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA282766 | Interrogating MRCK Protein Kinases in Ovarian Cancer | 000 | 1 | NIH | 2/7/2024 | $451,910 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA267678 | Positive Activities for Asian American Cancer Patients and Caregivers | 000 | 3 | NIH | 4/12/2024 | $249,000 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA289703 | Hepatic Tissue Integrity and Clonal Fitness: Key Factors in Controlling ?-Catenin Induced Oncogenesis | 000 | 1 | NIH | 2/22/2024 | $601,884 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA263017 | The role of MER/PROS1 in promoting stromal induced emergence from metastatic melanoma dormancy | 000 | 3 | NIH | 4/10/2024 | $249,000 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018146 | Examining the Relationship between Residential History at Midlife and Prostate Cancer Outcomes | 000 | 2 | NIH | 2/14/2024 | $470,592 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI171568 | Role of ZBP1 in pathogenesis of Salmonella biofilms | 000 | 2 | NIH | 4/11/2024 | $842,440 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD018511 | Neighborhood, social connectedness, and allostatic load in US Chinese immigrants | 000 | 2 | NIH | 12/9/2023 | $602,694 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD017675 | Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance | 001 | 2 | NIH | 12/7/2023 | $633,245 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA280446 | Interaction of cannabidiol (CBD) with targeted inhibitors of essential cancer signaling pathways | 001 | 2 | NIH | 4/25/2024 | -$10,517 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA280446 | Interaction of cannabidiol (CBD) with targeted inhibitors of essential cancer signaling pathways | 000 | 2 | NIH | 3/19/2024 | $210,338 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA281212 | Elucidating the critical role of Wee1 in GIST | 001 | 2 | NIH | 4/17/2024 | $21,503 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA281212 | Elucidating the critical role of Wee1 in GIST | 000 | 2 | NIH | 1/26/2024 | $387,045 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269975 | Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy | 001 | 2 | NIH | 4/17/2024 | $37,947 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA269975 | Small-molecule exploitation of ZBP1-driven nuclear necroptosis for cancer immunotherapy | 000 | 2 | NIH | 2/14/2024 | $683,088 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | K99GM148819 | Elucidating the epigenetic regulation of extracellular matrix and virus-induced fibroblast activation | 001 | 2 | NIH | 1/24/2024 | $125,000 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262551 | Folic Acid Supplementation and Colitis-associated Colon Carcinogenesis | 000 | 3 | NIH | 4/11/2024 | $525,677 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01GM141513 | Designing selective kinase inhibitors via deep learning | 000 | 3 | NIH | 11/9/2023 | $494,601 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM144131 | Deciphering Networks Controlling DNA Amplification | 000 | 3 | NIH | 10/31/2023 | $420,750 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA259244 | Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development | 001 | 3 | NIH | 4/18/2024 | $15,175 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R25CA259244 | Empowering the Next Generation of Cancer Professionals: the Fox Chase Cancer Center-University of Delaware Partnership for Undergraduate Research and Career Development | 000 | 3 | NIH | 2/19/2024 | $64,519 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00ES031148 | Repair of Oxidative Damage in G-Quadruplex Promoter DNA | 000 | 5 | NIH | 2/21/2024 | $249,000 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262466 | Assessing DNA polymerase theta as a therapeutic target in BRCA1 mutant cancer | 001 | 3 | NIH | 4/17/2024 | $21,503 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA262466 | Assessing DNA polymerase theta as a therapeutic target in BRCA1 mutant cancer | 000 | 3 | NIH | 2/5/2024 | $387,045 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA259188 | Investigating the IL-1R Pathway in Anaplastic Large Cell Lymphoma for Targeted Therapy | 000 | 4 | NIH | 4/5/2024 | $383,481 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R37AI110985 | Regulation of hematopoiesis by ribosomal protein paralogs | 000 | 10 | NIH | 1/23/2024 | $504,900 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R21CA289161 | NPC1 as a novel therapeutic target in ccRCC | 000 | 1 | NIH | 2/16/2024 | $219,725 |
| | 2024 | 2024 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R35GM119560 | Molecular Mechanisms Underlying Adaptor-Mediated Integrin Signaling in a Species-Specific Manner | 000 | 8 | NIH | 11/20/2023 | $433,373 |
| | 2024 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 1 | NIH | 4/12/2024 | $0 |
| | 2024 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD017675 | Reducing Urban Cervical Cancer Disparities Using a Tailored mHealth Intervention to Enhance Colposcopy Attendance | 000 | 1 | NIH | 12/7/2023 | $0 |
| | 2024 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | K99GM148819 | Elucidating the epigenetic regulation of extracellular matrix and virus-induced fibroblast activation | 000 | 1 | NIH | 12/2/2023 | $0 |
| | 2024 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R00CA263017 | The role of MER/PROS1 in promoting stromal induced emergence from metastatic melanoma dormancy | 001 | 2 | NIH | 4/23/2024 | $20,160 |
| | 2024 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 1 | NIH | 4/12/2024 | $0 |
| | 2024 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 1 | NIH | 4/12/2024 | $0 |
| | 2024 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 1 | NIH | 4/12/2024 | $0 |
| | 2024 | 2023 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | UG3HL170034 | Asian American Community Cohort and Equity Study (ACCESS) | 000 | 1 | NIH | 4/12/2024 | $0 |
| | 2024 | 2022 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA256762 | Identification of first-in-class epigenetic inhibitors that target Thymine DNA Glycosylase (TDG) for future precision therapy of metastatic melanoma | 000 | 2 | NIH | 4/11/2024 | $0 |
| | 2024 | 2022 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA256234 | Comprehensive identification of RAS mutations and allelic co-segregation patterns in colorectal cancer | 000 | 2 | NIH | 4/11/2024 | $0 |
| | 2024 | 2022 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD013347 | Extending a Caribbean Based Cohort to Promote US-Caribbean Comparisons to Facilitate Research Addressing Black Health Disparities | 000 | 5 | NIH | 3/4/2024 | $0 |
| | 2024 | 2022 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01MD012621 | Immigrant enclaves: Conferring health advantages or creating health disparities in Chinese immigrants? | 000 | 5 | NIH | 1/24/2024 | $0 |
| | 2024 | 2022 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI135025 | Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death | 001 | 6 | NIH | 1/2/2024 | $6,862 |
| | 2024 | 2022 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | P30CA006927 | Comprehensive Cancer Center Program at Fox Chase | 000 | 55 | NIH | 10/1/2023 | -$174,848 |
| | 2024 | 2021 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01CA212662 | Exploiting vulnerabilities in GIST using novel combination therapies | 000 | 5 | NIH | 1/29/2024 | $0 |
| | 2024 | 2021 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R56AI150965 | Harnessing ZBP1-driven cell death to improve influenza vaccine efficacy | 000 | 1 | NIH | 4/24/2024 | $0 |
| | 2024 | 2021 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R03CA219722 | Systematic study of variations in imaging techniques and response criteria for well differentiated pancreatic neuroendocrine tumors | 000 | 2 | NIH | 10/13/2023 | $0 |
| | 2024 | 2021 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI130022 | Hepatitis B virus cccDNA | 000 | 4 | NIH | 4/23/2024 | $0 |
| | 2024 | 2021 | THE INSTITUTE FOR CANCER RESEARCH | 333 COTTMAN AVE | PHILADELPHIA | PA | 19111-2434 | PHILADELPHIA | USA | R01AI135025 | Mechanism, Function, and Exploitation of Influenza A Virus-Activated Cell Death | 000 | 5 | NIH | 1/2/2024 | -$6,862 |
|
